- Research works
- 0 ▼ 100% vs 2013–17
- Citations
- 0 0.0 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: Clinuvel Pharmaceuticals (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Clinuvel Pharmaceuticals (Switzerland) publish most on?
By volume in 2022–2025: Drug Transport and Resistance Mechanisms, Epilepsy research and treatment and Cannabis and Cannabinoid Research.
- 1 Drug Transport and Resistance Mechanisms Oncology 0 works
- 2 Epilepsy research and treatment Psychiatry and Mental health 0 works
- 3 Cannabis and Cannabinoid Research Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Zug
- Varian Medical Systems (Switzerland)
- Biogen (Switzerland)
- University of Teacher Education Zug
- Amgen (Switzerland)
- AstraZeneca (Switzerland)
- RHI Magnesita (Switzerland)
- Johnson & Johnson (Switzerland)
- SHL Medical (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.